Antifungal hypersensitivity reactions and cross-reactivity patterns

Area of Science:

• Immunology
• Pharmacology
• Clinical Medicine

Background:

• Antifungal hypersensitivity reactions present as immediate or delayed types, with delayed T-cell mediated reactions being most common.
• Immediate reactions include non-Immunoglobulin E (IgE)-mediated mast cell activation and IgE-mediated responses.
• Understanding these reactions is crucial for safe and effective antifungal therapy.

Purpose of the Study:

• To provide an updated, evidence-based understanding of antifungal hypersensitivity.
• To outline strategies for recognizing clinical phenotypes, diagnosing reactions, and managing immediate and delayed hypersensitivity.
• To discuss implications of cross-reactivity for antifungal stewardship.

Main Methods:

• Review of current literature on antifungal hypersensitivity mechanisms and clinical presentations.
• Analysis of diagnostic approaches, including skin testing and drug challenges.
• Evaluation of management strategies for various hypersensitivity reaction types.

Main Results:

• Antifungal hypersensitivity encompasses a spectrum of reactions, from mild to severe.
• Diagnostic tools like skin testing and ex vivo assays can help confirm causality and assess cross-reactivity.
• Management involves identifying the reaction type and optimizing antifungal selection and duration.

Conclusions:

• A structured approach to recognizing, diagnosing, and managing antifungal hypersensitivity is essential for clinicians.
• Understanding drug hypersensitivity mechanisms and cross-reactivity patterns improves antifungal stewardship.
• Updated knowledge supports evidence-based clinical decision-making in managing patients with suspected antifungal hypersensitivity.